Chia-Cheng Tseng

418 total citations
19 papers, 326 citations indexed

About

Chia-Cheng Tseng is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Chia-Cheng Tseng has authored 19 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Chia-Cheng Tseng's work include Lung Cancer Research Studies (4 papers), Respiratory Support and Mechanisms (3 papers) and Nosocomial Infections in ICU (3 papers). Chia-Cheng Tseng is often cited by papers focused on Lung Cancer Research Studies (4 papers), Respiratory Support and Mechanisms (3 papers) and Nosocomial Infections in ICU (3 papers). Chia-Cheng Tseng collaborates with scholars based in Taiwan, United States and Japan. Chia-Cheng Tseng's co-authors include Meng‐Chih Lin, Kuo‐Tung Huang, Wen‐Feng Fang, Chin‐Chou Wang, Shih‐Feng Liu, Yung‐Che Chen, Hon‐Kan Yip, Cheng‐Ta Yang, Steve Leu and Huang‐Chih Chang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Nutrients.

In The Last Decade

Chia-Cheng Tseng

18 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chia-Cheng Tseng Taiwan 11 132 95 56 53 53 19 326
In Gyu Hyun South Korea 9 65 0.5× 139 1.5× 82 1.5× 30 0.6× 24 0.5× 32 327
Sandro Lindig Germany 7 102 0.8× 78 0.8× 110 2.0× 41 0.8× 12 0.2× 8 359
Foteini Economidou Greece 9 45 0.3× 204 2.1× 65 1.2× 62 1.2× 11 0.2× 12 377
Chongxiang Chen China 11 135 1.0× 121 1.3× 45 0.8× 47 0.9× 29 0.5× 23 510
Sotirios Kakavas Greece 12 53 0.4× 131 1.4× 30 0.5× 94 1.8× 24 0.5× 30 339
Maiko Kadowaki Japan 11 78 0.6× 169 1.8× 79 1.4× 47 0.9× 40 0.8× 19 346
Jyotsna Nateri United States 10 107 0.8× 61 0.6× 227 4.1× 54 1.0× 16 0.3× 13 498
Chunyin Wei China 10 112 0.8× 98 1.0× 27 0.5× 35 0.7× 80 1.5× 19 403
Takeo Azuhata Japan 9 190 1.4× 42 0.4× 87 1.6× 10 0.2× 41 0.8× 16 406
Ivette Buendía-Roldán Mexico 12 105 0.8× 106 1.1× 66 1.2× 60 1.1× 22 0.4× 52 372

Countries citing papers authored by Chia-Cheng Tseng

Since Specialization
Citations

This map shows the geographic impact of Chia-Cheng Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia-Cheng Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia-Cheng Tseng more than expected).

Fields of papers citing papers by Chia-Cheng Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia-Cheng Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia-Cheng Tseng. The network helps show where Chia-Cheng Tseng may publish in the future.

Co-authorship network of co-authors of Chia-Cheng Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Chia-Cheng Tseng. A scholar is included among the top collaborators of Chia-Cheng Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia-Cheng Tseng. Chia-Cheng Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Chen, Yung‐Che, Chang‐Chun Hsiao, Chao‐Chien Wu, et al.. (2022). Next generation sequencing reveals miR-431–3p/miR-1303 as immune-regulating microRNAs for active tuberculosis. Journal of Infection. 85(5). 519–533. 8 indexed citations
3.
Tseng, Chia-Cheng, Chih‐Yen Tu, Chia‐Hung Chen, et al.. (2021). Significance of the Modified NUTRIC Score for Predicting Clinical Outcomes in Patients with Severe Community-Acquired Pneumonia. Nutrients. 14(1). 198–198. 19 indexed citations
4.
Chen, Yu‐Mu, Chiung-Yu Lin, Yi‐Hsuan Tsai, et al.. (2021). Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR Mutation. Nutrients. 13(11). 3761–3761. 13 indexed citations
5.
Chang, Ya-Chun, Kuo‐Tung Huang, Yu‐Mu Chen, et al.. (2018). Ventilator Dependence Risk Score for the Prediction of Prolonged Mechanical Ventilation in Patients Who Survive Sepsis/Septic Shock with Respiratory Failure. Scientific Reports. 8(1). 5650–5650. 21 indexed citations
6.
Wang, Chin‐Chou, Chia-Cheng Tseng, Kuo‐Tung Huang, et al.. (2017). Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients. Oncotarget. 8(44). 75952–75967. 23 indexed citations
7.
Kang, Kyung Tae, et al.. (2017). Revisits after adenotonsillectomy in children with sleep‐disordered breathing: A retrospective single‐institution study. Clinical Otolaryngology. 43(1). 39–46. 19 indexed citations
8.
Tseng, Chia-Cheng, Chin‐Chou Wang, Chang‐Chun Hsiao, et al.. (2016). Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention. Tumor Biology. 37(9). 11873–11882. 6 indexed citations
9.
Liu, Shih‐Feng, Ho‐Chang Kuo, Hung‐Tu Huang, et al.. (2015). Leukocyte Mitochondrial DNA Copy Number Is Associated with Chronic Obstructive Pulmonary Disease. PLoS ONE. 10(9). e0138716–e0138716. 39 indexed citations
10.
Chen, Yin, Chia-Cheng Tseng, & Yi‐Ho Young. (2015). Acute hearing loss in the only hearing ear of 21 patients. Clinical Otolaryngology. 40(4). 382–385. 3 indexed citations
11.
Wang, Chin‐Chou, Chia-Cheng Tseng, Chang‐Chun Hsiao, et al.. (2014). Circulating Endothelial-Derived Activated Microparticle: A Useful Biomarker for Predicting One-Year Mortality in Patients with Advanced Non-Small Cell Lung Cancer. BioMed Research International. 2014. 1–11. 36 indexed citations
12.
Huang, Kuo‐Tung, Chien‐Hung Chin, Chia-Cheng Tseng, et al.. (2014). The Influence of Obesity on Different Genders in Patients with Obstructive Sleep Apnea. The Scientific World JOURNAL. 2014. 1–8. 10 indexed citations
13.
Tseng, Chia-Cheng, Chin‐Chou Wang, Huang‐Chih Chang, et al.. (2013). Levels of Circulating Microparticles in Lung Cancer Patients and Possible Prognostic Value. Disease Markers. 35(5). 301–310. 48 indexed citations
14.
Wang, Chin‐Chou, Chia-Cheng Tseng, Meng‐Chih Lin, et al.. (2012). Reinstitution of Mechanical Ventilation within 14 Days as a Poor Predictor in Prolonged Mechanical Ventilation Patients following Successful Weaning. The Scientific World JOURNAL. 2012. 1–6. 4 indexed citations
15.
Liu, Shih‐Feng, Chin‐Chou Wang, Chia-Cheng Tseng, et al.. (2012). The Clinical COPD Questionnaire Correlated with BODE Index-A Cross-Sectional Study. The Scientific World JOURNAL. 2012. 1–7. 9 indexed citations
16.
Huang, Kuo‐Tung, Chia-Cheng Tseng, Wen‐Feng Fang, & Meng‐Chih Lin. (2010). An early predictor of the outcome of patients with ventilator-associated pneumonia.. PubMed. 33(3). 274–82. 23 indexed citations
17.
Tseng, Chia-Cheng, et al.. (2009). Risk Factors for Mortality in Patients with NosocomialStenotrophomonas maltophiliaPneumonia. Infection Control and Hospital Epidemiology. 30(12). 1193–1202. 38 indexed citations
18.
Wu, Ming‐Feng, et al.. (2008). An acute injection of Porphyromonas gingivalis lipopolysaccharide modulates the OPG/RANKL system and interleukin‐6 in an ovariectomized mouse model. Oral Microbiology and Immunology. 23(3). 220–225. 6 indexed citations
19.
Shiraishi, Takahiro, Shiro Imai, Hideki Morimoto, et al.. (1990). [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].. PubMed. 25(5). 997–1012. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026